
NYSEHealthcareMedical - Devices
أحدث البيانات المتاحة
118.69 US$
−0.78 US$ · -0.65%
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
الإغلاق السابق
118.69 US$
−0.78 US$ · -0.65%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
نطاق اليوم
السعر الحالي 118.69 US$
نطاق 52 أسبوعًا
السعر الحالي 118.69 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
76
أقل من القيمة
المشاعر
61
صعودي
المخاطر
30
مخاطر متوسطة
الزخم
52
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
نطاق اليوم
السعر الحالي 118.69 US$
نطاق 52 أسبوعًا
السعر الحالي 118.69 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 1.33 مليار USD | 1.36 مليار USD | 1.31 مليار USD | 1.17 مليار USD | 993.2 مليون USD |
| تكلفة البضاعة المباعة | 590.44 مليون USD | 582.28 مليون USD | 597.14 مليون USD | 545.79 مليون USD | 462.43 مليون USD |
| الربح الإجمالي | 743.59 مليون USD | 778.55 مليون USD | 711.92 مليون USD | 622.87 مليون USD | 530.77 مليون USD |
| البحث والتطوير | 59.77 مليون USD | 69.42 مليون USD | 63.04 مليون USD | 58.63 مليون USD | 55.2 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 442.42 مليون USD | 422.05 مليون USD | 420.82 مليون USD | 373.95 مليون USD | 332.2 مليون USD |
| نفقات التشغيل | 502.19 مليون USD | 556.73 مليون USD | 547.03 مليون USD | 466.84 مليون USD | 450.02 مليون USD |
| مصاريف الفوائد | 28.7 مليون USD | 9.75 مليون USD | 13.02 مليون USD | 14.63 مليون USD | 17.12 مليون USD |
| الاستهلاك والإطفاء | 111.72 مليون USD | 115.59 مليون USD | 97.22 مليون USD | 93.31 مليون USD | 97.75 مليون USD |
| الدخل التشغيلي | 241.4 مليون USD | 221.82 مليون USD | 164.88 مليون USD | 156.03 مليون USD | 80.75 مليون USD |
| صافي الدخل | 97.31 مليون USD | 167.68 مليون USD | 117.56 مليون USD | 115.4 مليون USD | 43.38 مليون USD |
تم تحديث حقائق الشركة 10 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI148.96 مليون0.01%2.3 ترليون USD0.03%381.94 US$+0.63%
iShares Russell 2000 ETFIWM145.06 مليون0.19%78.27 مليار USD0.19%278.94 US$+0.49%
Vanguard Morningstar Small-Cap ETFVB107.76 مليون0.06%185.3 مليار USD0.03%289.48 US$+0.64%
Vanguard Extended Market ETFVXF55.66 مليون0.06%95.4 مليار USD0.05%235 US$+0.80%
iShares Russell 2000 Growth ETFIWO47.99 مليون0.35%13.97 مليار USD0.24%356.78 US$+0.94%
Dimensional - US Small Cap ETFDFAS42.14 مليون0.12%33.87 مليار USD0.31%78.35 US$+0.32%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY40.38 مليون0.16%25.58 مليار USD0.23%669.87 US$+0.54%
Vanguard Morningstar Small-Cap Value ETFVBR34.22 مليون0.05%68.2 مليار USD0.05%234.43 US$+0.22%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Dimensional - US Small Cap ETFDFAS
State Street SPDR S&P MIDCAP 400 ETF TrustMDY
Vanguard Morningstar Small-Cap Value ETFVBRالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.